We have all the details on a former Nemours scientist who admitted to misconduct after working there for more than 15 years. Plus, Try again: Philly judge orders retrial after $45 million malpractice ...
Engineers have modified lipid nanoparticles (LNPs) -- the revolutionary technology behind the COVID-19 mRNA vaccines -- to not only cross the blood-brain barrier (BBB) but also to target specific ...
Researchers have developed lipid nanoparticles (LNPs) that cross the blood-brain barrier (BBB) and precisely target brain cells, a major step toward treating neurological diseases like Alzheimer’s.